Jefferies Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-24,400
Closed -$57.3K 1224
2021
Q1
$57.3K Buy
+24,400
New +$57.3K ﹤0.01% 1007
2019
Q3
Sell
-10,577
Closed -$12K 1808
2019
Q2
$12K Sell
10,577
-76,612
-88% -$86.9K ﹤0.01% 1507
2019
Q1
$114K Sell
87,189
-132,143
-60% -$173K ﹤0.01% 1326
2018
Q4
$200K Buy
219,332
+84,948
+63% +$77.5K ﹤0.01% 1148
2018
Q3
$276K Buy
134,384
+98,354
+273% +$202K ﹤0.01% 1207
2018
Q2
$65K Buy
+36,030
New +$65K ﹤0.01% 1466